Kristi McLendon

Pharmacokinetic equivalence of CT‐P39 and reference omalizumab in healthy individuals: A randomised, double‐blind, parallel‐group, Phase 1 trial

Marcus Maurer, Sarbjit S. Saini, Kristi McLendon et al. · Clinical and Translational Allergy · 2022 · 13 citations · Full text

A randomized, double-blind, 3-arm, parallel study assessing the pharmacokinetics, safety, tolerability and immunogenicity of AVT04, an ustekinumab candidate biosimilar, in healthy adults

Christopher Wynne, Paul Hamilton, Kristi McLendon et al. · Expert Opinion on Investigational Drugs · 2023 · 13 citations · Full text

A first‐in‐human, randomized study of the safety, pharmacokinetics and pharmacodynamics of povetacicept, an enhanced dual BAFF/APRIL antagonist, in healthy adults

R. H. Davies, Stanford L. Peng, Jason D. Lickliter et al. · Clinical and Translational Science · 2024 · 10 citations · Full text